New Meetings

11th Working Group on MedDRA IWG Meeting, Geneva, Switzerland, 22-23 March 2017

CIOMS 84th Executive Committee Meeting, Geneva, Switzerland, 28 November 2017

 

Recent Meetings

83rd CIOMS Executive Committee/General Assembly Meeting, Geneva, Switzerland, 29 November 2016

10th Working Group on MedDRA IWG Meeting, Geneva, Switzerland, 6-7 September 2016

10th Working Group Meeting on Revision of CIOMS International Ethical Guidelines, Utrecht, Netherlands, 1-3 June 2016

8th CIOMS Working Group Meeting on Vaccine Safety, Accra, Ghana, 22-23 March 2016

9th Working Group on MedDRA IWG Meeting, Geneva, Switzerland, 15-16 March 2016

82nd CIOMS Executive Committee Meeting, Geneva, Switzerland, 8 December 2015

ISoP meeting, Prague, Czech Republic, 27-30 October 2015

8th Working Group on MedDRA IWG Meeting, Geneva, Switzerland, 24-25 September 2015

7th CIOMS Working Group meeting on Vaccine Safety, near Philadelphia, PA, USA, 21-22 September 2015

8th Working Group X on Meta-analysis, New Brunswick, NJ, USA, 1-2 July 2015

9th Working Group on Revision of CIOMS International Ethical Guidelines, Paris, France, 14-16 June 2015

th Working Group on MedDRA IWG, Chavannes-de-Bogis, Switzerland, 19-20 May 2015

8th Working Group on Revision of CIOMS International Ethical Guidelines, Vilnius, Lithuania, 22-24 March 2015

6th Vaccine Safety Working Group, Lyon, France, 18-19 March 2015 

ISoP Meeting, Mysore, India, 12-14 January 2015

 

WHO on Twitter

WHO R&D: There are 340 new products in the pipeline (as of Dec. 2016) for neglected diseases & select priority pathogen… https://t.co/q5jwlIR7m6
11hreplyretweetfavorite
WHO There are 352 times more health researchers in high-income countries than in low-income countries… https://t.co/m22LQGiczk
12hreplyretweetfavorite
WHO Gaps in R&D investment & the pipeline for antimicrobial medicines have become a cause of concern in the context of #AntimicrobialResistance
13hreplyretweetfavorite
WHO Ebola in W. Africa exposed lack of investment in products & approaches to prevent & minimize the impact of pathogens with epidemic potential
14hreplyretweetfavorite
WHO As little as 1% of all funding for health R&D is allocated to diseases such as malaria & TB https://t.co/otGpqN0Ox3
15hreplyretweetfavorite

Visitors

1276824

Member Login

Member Login